The impact of non-medical switching among ambulatory patients: an updated systematic literature review
Background: Non-medical switching (NMS) is defined as switching to a clinically similar but chemically distinct medication for reasons apart from lack of effectiveness, tolerability or adherence. Objective: To update a prior systematic review evaluating the impact of NMS on outcomes. Data sources: A...
Saved in:
| Main Authors: | Erin R. Weeda, Elaine Nguyen, Silas Martin, Michael Ingham, Diana M. Sobieraj, Brahim K. Bookhart, Craig I. Coleman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20016689.2019.1678563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specialist physician perspectives on non-medical switching of prescription medications
by: Olivia S. Costa, et al.
Published: (2020-01-01) -
Safety of Switching from a Reference Biologic to Its Biosimilar: A Systematic Review and Meta-Analysis
by: Sarah Saad Aljahili, et al.
Published: (2025-02-01) -
Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers
by: Fernando Perez-Ruiz, et al.
Published: (2024-09-01) -
Impact of non-medical switching of prescription medications on health outcomes: an e-survey of high-volume medicare and medicaid physician providers
by: Craig Coleman, et al.
Published: (2020-01-01) -
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study
by: David M. Pariser, et al.
Published: (2025-03-01)